Cetera Advisor Networks LLC Repligen Corp Transaction History

Cetera Advisor Networks LLC

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$170.78 - $208.42 $24,250 - $29,595	142 Added 4.56%	3,256 $598,000
Q4 2023 Feb 13, 2024	SELL	$114.17 - $185.35 $32,652 - $53,010	-286 Reduced 8.41%	3,114 $559,000
Q3 2023 Nov 14, 2023	SELL	$138.78 - $176.51 $1,526 - $1,941	-11 Reduced 0.32%	3,400 $540,000
Q2 2023 Aug 09, 2023	BUY	$138.42 - $180.31 $64,918 - $84,565	469 Added 15.94%	3,411 $482,000
Q1 2023 May 15, 2023	SELL	$154.26 - $198.1 $96,875 - $124,406	-628 Reduced 17.59%	2,942 $495,000
Q4 2022 Feb 14, 2023	BUY	$162.42 - $220.56 $246,228 - $334,368	1,516 Added 73.81%	3,570 $604,000
Q3 2022 Nov 10, 2022	BUY	$160.42 - $256.21 $17,325 - $27,670	108 Added 5.55%	2,054 $384,000
Q2 2022 Aug 11, 2022	SELL	$140.68 - $188.02 $38,124 - $50,953	-271 Reduced 12.22%	1,946 $316,000
Q1 2022 May 12, 2022	SELL	$161.19 - $257.96 $31,754 - $50,818	-197 Reduced 8.16%	2,217 $417,000
Q4 2021 Feb 14, 2022	SELL	$247.59 - $304.47 $5,942 - $7,307	-24 Reduced 0.98%	2,414 $639,000
Q3 2021 Nov 16, 2021	SELL	$194.77 - $324.21 $89,594 - $149,136	-460 Reduced 15.87%	2,438 $705,000
Q2 2021 Aug 13, 2021	BUY	$165.87 - $220.95 $480,691 - $640,313	2,898 New	2,898 $578,000
Q1 2021 May 17, 2021	SELL	$180.37 - $226.26 $209,048 - $262,235	-1,159 Closed	0 $0
Q4 2020 Feb 17, 2021	BUY	$148.08 - $206.57 $171,624 - $239,414	1,159 New	1,159 $222,000
Q3 2020 Nov 13, 2020	SELL	$122.51 - $158.27 $1.61 Million - $2.08 Million	-13,172 Closed	0 $0
Q2 2020 Aug 13, 2020	BUY	$94.33 - $140.48 $1.24 Million - $1.85 Million	13,172 New	13,172 $1.63 Million

485

54.1M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $9.21B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

Stay updated on Cetera Advisor Networks LLC with notifications on news.